Quantcast
Last updated on April 24, 2014 at 17:35 EDT

Latest Cyberknife Stories

2013-11-25 08:27:50

More than 700 CyberKnife® and TomoTherapy® Systems Have Treated More Than Half a Million Patients Worldwide SUNNYVALE, Calif., Nov. 25, 2013 /PRNewswire/ -- Accuray Incorporated (Nasdaq: ARAY) announced today continued momentum in global adoption of its CyberKnife® and TomoTherapy® Systems. Accuray has expanded its installed base to more than 700 systems worldwide which have been used to treat more than half a million patients, further positioning the company as a leader in...

2013-11-07 16:29:08

UCLA Researchers Evaluate Long-term Outcomes of More than 1,000 Patients from Multiple Institutions SUNNYVALE, Calif., Nov. 7, 2013 /PRNewswire/ -- Accuray Incorporated (Nasdaq: ARAY), announced today the publication of two papers stemming from a large multi-center study of CyberKnife® stereotactic body radiotherapy (SBRT) led by investigators at the University of California, Los Angeles (UCLA). The first paper, published in the September 2013 online issue of Radiotherapy &...

2013-10-09 08:24:12

NEW YORK, October 9, 2013 /PRNewswire/ -- Editor Note: For more information about this release, please scroll to bottom. Today, Analysts' Corner announced new research reports highlighting Amarin Corporation plc (NASDAQ: AMRN), Discovery Laboratories Inc. (NASDAQ: DSCO), Auxilium Pharmaceuticals Inc. (NASDAQ: AUXL), Novavax, Inc. (NASDAQ: NVAX), and Accuray Incorporated (NASDAQ: ARAY). Today's readers may access these reports free of charge - including full price...

2013-10-03 08:30:13

Data Supports Growing Use of CyberKnife® SBRT for Prostate Cancer SUNNYVALE, Calif., Oct. 3, 2013 /PRNewswire/ -- ASTRO 2013 (Atlanta) - Accuray Incorporated (Nasdaq: ARAY) announced today that studies presented at the 55th Annual American Society for Radiation Oncology (ASTRO) Meeting in Atlanta, September 22 - 25, 2013 continue to reinforce evidence of clinical and quality of life benefits for the CyberKnife® and TomoTherapy® Systems. A variety of indications including prostate,...

2013-09-22 08:20:18

World's Largest Annual Gathering of the Radiation Oncology Community Provides Multiple Opportunities to Learn about the CyberKnife® M6(TM) Series and the TomoTherapy® H(TM) Series Systems SUNNYVALE, Calif. and ATLANTA, Sept. 22, 2013 /PRNewswire/ -- ASTRO 2013 -- Accuray Incorporated (Nasdaq: ARAY) announced today its momentum in gaining adoption for both the new CyberKnife® M6(TM) Series and TomoTherapy® H(TM) Series Systems at the 55th Annual American Society for Radiation...

2013-09-03 08:28:51

Accuray Appoints Successor SUNNYVALE, Calif., Sept. 3, 2013 /PRNewswire/ -- Accuray Incorporated (Nasdaq: ARAY), announced today that Derek Bertocci has resigned as Senior Vice President and Chief Financial Officer of the company effective September 2, 2013. Today, Accuray has appointed Gregory Lichtwardt, executive vice president, chief financial officer, effective immediately. Mr. Bertocci is anticipated to continue in a consulting role with the Company. Mr. Lichtwardt, age 59,...

2013-06-13 08:28:13

Lancaster General Health Unveils Leading Robotic Radiosurgery System SUNNYVALE, Calif., June 13, 2013 /PRNewswire/ -- Accuray Incorporated (Nasdaq: ARAY) announced today that Lancaster General Health in Pennsylvania is the first U.S. center to treat a patient with the CyberKnife® M6(TM) System, the most advanced robotic radiosurgery system in the world and the latest generation of the CyberKnife System. The new CyberKnife M6 System was designed to provide clinicians with an...

2013-06-05 08:28:29

Advanced Radiation Treatment Now Available to Cancer Patients in France SUNNYVALE, Calif., June 5, 2013 /PRNewswire/ -- Accuray Incorporated (Nasdaq: ARAY), announced today the first patient has been treated with its new TomoHDA(TM) System at Centre Oscar Lambret in Lille, France. Building upon the proven TomoTherapy® Hi-Art® and TomoHD(TM) technologies, the TomoHDA System is a fully-integrated radiation therapy system designed to treat the full spectrum of cancer...

2013-05-21 08:29:54

Updated ASTRO Model Policy Endorses Stereotactic Body Radiation Therapy (SBRT) for Prostate Cancer SUNNYVALE, Calif., May 21, 2013 /PRNewswire/ -- Accuray Incorporated (Nasdaq: ARAY), announced today the publication of study results involving hundreds of prostate cancer patients treated with the CyberKnife® Robotic Radiosurgery System, the most widely used form of prostate stereotactic body radiation therapy (SBRT). The study followed 304 patients for a median of 5 years, and...

2013-04-22 08:28:50

More than 800 oncology professionals at European Society for Radiotherapy and Oncology forum hear of pioneering treatment delivery, motion management and tumor-tracking technologies for tackling the growing lung cancer burden GENEVA, April 22, 2013 /PRNewswire/ -- Cancer experts have reported future trends and progress in radiotherapy treatments for lung cancer using motion management and tumor-tracking technologies from Varian Medical Systems (NYSE: VAR). Speakers at Varian's...